Clinical Trial Update: The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the immunogenicity and safety of the seasonal trivalent influenza vaccine in patients with chronic kidney disease not on dialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Seasonal trivalent influenza vaccine (Influenza vaccine, inactivated, trivalent)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Immunogenicity and Adverse Drug Effect of Vaccines Influenza, Chronic Kidney Disease | Phase 4 | Status: UNKNOWN